Pediatric Bone Sarcoma Panel - Disclosures
Panel Member
|
Safia Ahmed MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Catherine Albert MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
John Howard Alexander MD |
Grant/Research Support
|
| Richo/Stratasys |
Date Completed
|
05/10/2024 |
Panel Member
|
Alyaa Al-Ibraheemi MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jenna Allison MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Peter Anderson MD, PhD |
Royalty Income
|
| Enlivity |
Date Completed
|
09/26/2024 |
Panel Member
|
Amy Armstrong MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jamie Aye MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Naomi Balamuth MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Odion Binitie MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Marian Birkeland PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Emily Blauel MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Scott Borinstein MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jessica Davis MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Matthew Dietz DO, MSEd |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mary Dwyer MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ajay Gupta MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Rex Haydon MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Paula Head |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jason Hearn MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Hennessy MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Jordan Holmes MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kelly Horst MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Katherine Janeway MD, MMSc |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Frankie Jones |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brian Ladle MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Patrick Leavey MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
John Livingston MD, MS |
Grant/Research Support
|
| Exelixis Inc. | Genentech, Inc. |
Date Completed
|
07/01/2024 |
Panel Member
|
Daniel Lui PharmD, BCPPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kyle MacQuarrie MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Amanda Marinoff MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lorenzo Nardo MD, PhD |
Fellowship Support
|
| United Imaging Healthcare - Lorenzo Nardo has is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-sharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. Lorenzo Nardo has been the PI of more than 1 service agreements wi | United Imaging Healthcare - Lorenzo Nardo is mentioned in a recurrent gift to support the American Board of Radiology Alternate Pathway at UC Davis |
Grant/Research Support
|
| Curium Pharma Healthcare- Lorenzo Nardo is PI of a clinical trial partially supported by Curium Pharma Healthcare | Lantheus - Lorenzo Nardo is PI of a clinical trial partially supported by Lantheus | Lilly - Lorenzo Nardo is Co-I of a clinical trial supported by Lilly; in addition I have signed a honorarium agreement with them, however, I was never paid. | Novartis Pharmaceuticals Corporation | Telix Pharmaceuticals - Lorenzo Nardo is PI of a clinical trial partially supported by Telix | United Imaging Healthcare - Lorenzo Nardo has is principal investigator of a service agreement with United Imaging Healthcare. UC Davis has a revenue-sharing agreement with United Imaging Healthcare that is based on uEXPLORER sales. Lorenzo Nardo has been the PI of more than 1 service agreements wi |
Non-royalty Payments
|
| ABR - Lorenzo Nardo served as committee member for the American Board of Radiology - multiple committees. |
Salary
|
| Elsivier - Associate editor for Current Problems in Cancer | European Health and Digital Executive Agency- Lorenzo Nardo served a panel reviewer for the European Health and Digital Executive Agency | National Institutes for Health (NIH) - worked in study sections and funded by NIH grant for most of my salary |
Date Completed
|
05/12/2025 |
Panel Member
|
Kirsten Ness PhD, PT |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Svitlana Ostanina PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Allison Pribnow MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Damon Reed MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Katie Stehman MMS, PA-C |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Veronica Sullins MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Samantha Tamburro BSN, RN, CPON |
Salary
|
| Flatiron Health, Inc. |
Date Completed
|
10/24/2024 |
Panel Member
|
Lars Wagner MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Janet Yoon MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |